Recovery
This product scores low due to predominant reliance on animal data with scant human trials lacking controls or large samples. Examine.com rates BPC-157 as investigational with high rat efficacy (e.g., Achilles tendon healing via IP 10 ug/kg) but 'little evidence for people.' TB-500 has phase I safety (PMID:34346165, up to 5 ug/kg x10 days, mild AEs) but no efficacy RCTs. FDA Category 2 status signals unknown risks, overriding small pilot safety data (e.g., 20mg IV BPC PMID:40131143). Nasal deliv
Avoid this unapproved peptide blend due to FDA safety concerns and lack of human clinical evidence. Animal studies are promising but insufficient for recovery claims. Opt for proven, regulated alternatives like physical therapy or evidence-based supplements.